Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and aging

GLIA

Volumn 57, Issue 15, 2009, Pages 1579-1587

  Copray, Sjef ^a   Huynh, Jimmy Long ^b   Sher, Falak ^a   Casaccia Bonnefil, Patrizia ^b   Boddeke, Erik ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Histone modification; micro RNA; Multiple sclerosis; Oligodendrocyte differentiation

Indexed keywords

HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEMETHYLASE; HISTONE METHYLTRANSFERASE; MICRORNA; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

AGING; CELL MATURATION; CHROMATIN STRUCTURE; CONSTITUTIVE HETEROCHROMATIN; DNA METHYLATION; ENZYME ACTIVITY; EPIGENETICS; GENE EXPRESSION REGULATION; GENOMIC IN SITU HYBRIDIZATION; HISTONE CODE; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEOSOME; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; REMYELINIZATION; REVIEW; SIGNAL TRANSDUCTION;

AGING; CELL DIFFERENTIATION; CHROMATIN; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTONES; HUMANS; MODELS, BIOLOGICAL; OLIGODENDROGLIA; REGENERATION;

EID: 70449650339     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20881     Document Type: Review

References (96)

1. Asklund T, Appelskog IB, Ammerpohl O, Ekstrom TJ, Almqvist PM. 2004. Histone deacetylase inhibitor 4-phenylbutyrate modulates glial fibrillary acidic protein and connexin 43 expression, and enhances gap-junction communication, in human glioblastoma cells. Eur J Cancer 40:1073-1081. (Pubitemid 38496266)
2. Bartova E, Krejci J, Harnicarova A, Galiova G, Kozubek S. 2008. Histone modifications and nuclear architecture: A review. J Histochem Cytochem 56:711-721. (Pubitemid 351991084)
3. Battiste J, Helms AW, Kim EJ, Savage TK, Lagace DC, Mandyam CD, Eisch AJ, Miyoshi G, Johnson JE. 2007. Ascl1 defines sequentially generated lineage-restricted neuronal and oligodendrocyte precursor cells in the spinal cord. Development 134:285-293. (Pubitemid 46252415)
4. Benevolenskaya EV. 2007. Histone H3K4 demethylases are essential in development and differentiation. Biochem Cell Biol 85:435-443. (Pubitemid 47518039)
5. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, Levine SS, Wernig M, Tajonar A, Ray MK, Bell GW, Otte AP, Vidal M, Gifford DK, Young RA, Jaenisch R. 2006. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441:349-353. (Pubitemid 44050199)
6. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME. 2004. Stressdependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011-2015. (Pubitemid 38393275)
7. Cai J, Qi Y, Hu X, Tan M, Liu Z, Zhang J, Li Q, Sander M, Qiu M. 2005. Generation of oligodendrocyte precursor cells from mouse dorsal spinal cord independent of Nkx6 regulation and Shh signaling. Neuron 45:41-53. (Pubitemid 40075348)
8. Casaccia-Bonnefil P, Pandozy G, Mastronardi F. 2008. Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: A contribution to the current debate on disease pathogenesis. Prog Neurobiol 86:368-378.
9. Chari DM. 2007. Remyelination in multiple sclerosis. Int Rev Neurobiol 79:589-620.
10. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38:228-233. (Pubitemid 43177239)
11. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, Bronson R, Appella E, Alt FW, Chua KF. 2003. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 100:10794-10799. (Pubitemid 37140107)
12. Cheng X, Zhang X. 2007. Structural dynamics of protein lysine methylation and demethylation. Mutat Res 618:102-115. (Pubitemid 46574740)
13. Chopra VS, Mishra RK. 2005. To SIR with Polycomb: Linking silencing mechanisms. Bioessays 27:119-121.
14. Cress WD, Seto E. 2000. Histone deacetylases, transcriptional control, and cancer. J Cell Physiol 184:1-16. (Pubitemid 30349623)
15. Culhane JC, Cole PA. 2007. LSD1 and the chemistry of histone demethylation. Curr Opin Chem Biol 11:561-568.
16. D'Souza CA, Wood DD, She YM, Moscarello MA. 2005. Autocatalytic cleavage of myelin basic protein: An alternative to molecular mimicry. Biochemistry 44:12905-12913.
17. Dyson MH, Thomson S, Inagaki M, Goto H, Arthur SJ, Nightingale K, Iborra FJ, Mahadevan LC. 2005. MAP kinase-mediated phosphorylation of distinct pools of histone H3 at S10 or S28 via mitogen- and stress-activated kinase 1/2. J Cell Sci 118:2247-2259. (Pubitemid 40872846)
18. Erhardt S, Su IH, Schneider R, Barton S, Bannister AJ, Perez-Burgos L, Jenuwein T, Kouzarides T, Tarakhovsky A, Surani MA. 2003. Consequences of the depletion of zygotic and embryonic enhancer of zeste 2 during preimplantation mouse development. Development 130:4235-4248. (Pubitemid 37185314)
19. Finch PR, Moscarello MA. 1972. A myelin protein fraction extracted with thioethanol. Brain Res 42:177-187.
20. Franklin RJ, Ffrench-Constant C. 2008. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci 9:839-855.
21. He Y, Dupree J, Wang J, Sandoval J, Li J, Liu H, Shi Y, Nave KA, Casaccia-Bonnefil P. 2007a. The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 55:217-230. (Pubitemid 47048909)
22. He Y, Sandoval J, Casaccia-Bonnefil P. 2007b. Events at the transition between cell cycle exit and oligodendrocyte progenitor differentiation: The role of HDAC and YY1. Neuron Glia Biol 3:221-231. (Pubitemid 351594227)
23. Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH. 2004. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci USA 101:16659-16664. (Pubitemid 39557769)
24. Imai S, Armstrong CM, Kaeberlein M, Guarente L. 2000. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403:795-800. (Pubitemid 30111843)
25. Iniguez-Lluhi JA. 2006. For a healthy histone code, a little SUMO in the tail keeps the acetyl away. ACS Chem Biol 1:204-206.
26. Ivey KN, Muth A, Arnold J, King FW, Yeh RF, Fish JE, Hsiao EC, Schwartz RJ, Conklin BR, Bernstein HS, Srivastava D. 2008. Micro- RNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2:219-229. (Pubitemid 351298595)
27. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, Brummelkamp TR, Fleming MD, Camargo FD. 2008. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451:1125-1129. (Pubitemid 351317447)
28. Kessaris N, Fogarty M, Iannarelli P, Grist M,Wegner M, Richardson WD. 2006. Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nat Neurosci 9:173-179. (Pubitemid 43164539)
29. Kessaris N, Pringle N, Richardson WD. 2008. Specification of CNS glia from neural stem cells in the embryonic neuroepithelium. Philos Trans R Soc Lond B Biol Sci 363:71-85. (Pubitemid 350174580)
30. Kondo T, Raff M. 2000a. Basic helix-loop-helix proteins and the timing of oligodendrocyte differentiation. Development 127:2989-2998. (Pubitemid 30611892)
31. Kondo T, Raff M. 2000b. The Id4 HLH protein and the timing of oligodendrocyte differentiation. EMBO J 19:1998-2007. (Pubitemid 30237575)
32. Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C, Jensen K, Cobb BS, Merkenschlager M, Rajewsky N, Rajewsky K. 2008. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132:860-874. (Pubitemid 351312808)
33. Krichevsky AM, Sonntag KC, Isacson O, Kosik KS. 2006. Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 24:857-864.
34. Lan F, Nottke AC, Shi Y. 2008. Mechanisms involved in the regulation of histone lysine demethylases. Curr Opin Cell Biol 20:316-325.
35. Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, Pelicci PG, Kouzarides T. 2002. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 21:2383-2396.
36. Lau P, Verrier JD, Nielsen JA, Johnson KR, Notterpek L, Hudson LD. 2008. Identification of dynamically regulated microRNA and mRNA networks in developing oligodendrocytes. J Neurosci 28:11720-11730.
37. Liu A, Han YR, Li J, Sun D, Ouyang M, Plummer MR, Casaccia- Bonnefil P. 2007. The glial or neuronal fate choice of oligodendrocyte progenitors is modulated by their ability to acquire an epigenetic memory. J Neurosci 27:7339-7343. (Pubitemid 47037547)
38. Liu A, Li J, Marin-Husstege M, Kageyama R, Fan Y, Gelinas C, Casaccia-Bonnefil P. 2006. A molecular insight of Hes5-dependent inhibition of myelin gene expression: Old partners and new players. EMBO J 25:4833-4842. (Pubitemid 44607028)
39. Liu H, Hu Q, D'ercole AJ, Ye P. 2009. Histone deacetylase 11 regulates oligodendrocyte-specific gene expression and cell development in OL-1 oligodendroglia cells. Glia 57:1-12.
40. Lu J, Guo S, Ebert BL, Zhang H, Peng X, Bosco J, Pretz J, Schlanger R, Wang JY, Mak RH, Dombkowski DM, Preffer FI, Scadden DT, Golub TR. 2008. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell 14:843-853. (Pubitemid 351757199)
41. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W. 2001. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107:137-148. (Pubitemid 33035941)
42. Lyssiotis CA, Walker J, Wu C, Kondo T, Schultz PG, Wu X. 2007. Inhibition of histone deacetylase activity induces developmental plasticity in oligodendrocyte precursor cells. Proc Natl Acad Sci USA 104:14982-14987.
43. Marin-Husstege M, He Y, Li J, Kondo T, Sablitzky F, Casaccia-Bonnefil P. 2006. Multiple roles of Id4 in developmental myelination: Predicted outcomes and unexpected findings. Glia 54:285-296. (Pubitemid 44316233)
44. Marin-Husstege M, Muggironi M, Liu A, Casaccia-Bonnefil P. 2002. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. J Neurosci 22:10333-10345. (Pubitemid 35416871)
45. Mastronardi FG, Noor A, Wood DD, Paton T, Moscarello MA. 2007. Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated. J Neurosci Res 85:2006-2016. (Pubitemid 47051489)
46. Mastronardi FG, Wood DD, Mei J, Raijmakers R, Tseveleki V, Dosch HM, Probert L, Casaccia-Bonnefil P, Moscarello MA. 2006. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: A role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J Neurosci 26:11387-11396. (Pubitemid 44772168)
47. Moscarello MA, Brady GW, Fein DB, Wood DD, Cruz TF. 1986. The role of charge microheterogeneity of basic protein in the formation and maintenance of the multilayered structure of myelin: A possible role in multiple sclerosis. J Neurosci Res 15:87-99.
48. Moscarello MA, Mastronardi FG, Wood DD. 2007. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem Res 32:251-256.
49. Moscarello MA, Wood DD, Ackerley C, Boulias C. 1994. Myelin in multiple sclerosis is developmentally immature. J Clin Invest 94:146-154. (Pubitemid 24218087)
50. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M, Guarente L. 2004. Mammalian SIRT1 represses forkhead transcription factors. Cell 116:551-563. (Pubitemid 38264432)
51. Musse AA, Boggs JM, Harauz G. 2006. Deimination of membranebound myelin basic protein in multiple sclerosis exposes an immunodominant epitope. Proc Natl Acad Sci USA 103:4422-4427.
52. Nelson PT, Wang WX, Rajeev BW. 2008. MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol 18:130-138.
53. Nicolay DJ, Doucette JR, Nazarali AJ. 2007. Transcriptional control of oligodendrogenesis. Glia 55:1287-1299.
54. Nielsen JA, Hudson LD, Armstrong RC. 2002. Nuclear organization in differentiating oligodendrocytes. J Cell Sci 115:4071-4079.
55. Paik WK, Paik DC, Kim S. 2007. Historical review: The field of protein methylation. Trends Biochem Sci 32:146-152. (Pubitemid 46367693)
56. Pal S, Sif S. 2007. Interplay between chromatin remodelers and protein arginine methyltransferases. J Cell Physiol 213:306-315. (Pubitemid 47509707)
57. Plath K, Fang J, Mlynarczyk-Evans SK, Cao R, Worringer KA, Wang H, de la Cruz CC, Otte AP, Panning B, Zhang Y. 2003. Role of histone H3 lysine 27 methylation in X inactivation. Science 300:131-135. (Pubitemid 36423045)
58. Ptashne M. 2007. On the use of the word 'epigenetic'. Curr Biol 17:R233-R236.
59. Richardson WD, Kessaris N, Pringle N. 2006. Oligodendrocyte wars. Nat Rev Neurosci 7:11-18.
60. Romm E, Nielsen JA, Kim JG, Hudson LD. 2005. Myt1 family recruits histone deacetylase to regulate neural transcription. J Neurochem 93:1444-1453. (Pubitemid 40853267)
61. Samanta J, Kessler JA. 2004. Interactions between ID, OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 131:4131-4142. (Pubitemid 39276185)
62. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M, Greenberg ME. 2006. A brain-specific microRNA regulates dendritic spine development. Nature 439:283-289.
63. Shen S, Casaccia-Bonnefil P. 2008. Post-translational modifications of nucleosomal histones in oligodendrocyte lineage cells in development and disease. J Mol Neurosci 35:13-22.
64. Shen S, Li J, Casaccia-Bonnefil P. 2005. Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J Cell Biol 169:577-589.
65. Shen S, Sandoval J, Swiss VA, Li J, Dupree J, Franklin RJ, Casaccia- Bonnefil P. 2008. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci 11:1024-1034.
66. Sher F, Balasubramaniyan V, Boddeke E, Copray S. 2008a. Oligodendrocyte differentiation and implantation: New insights for remyelinating cell therapy. Curr Opin Neurol 21:607-614.
67. Sher F, Rossler R, Brouwer N, Balasubramaniyan V, Boddeke E, Copray S. 2008b. Differentiation of neural stem cells into oligodendrocytes: Involvement of the polycomb group protein Ezh2. Stem Cells 26:2875-2883.
68. Shields S, Gilson J, Blakemore W, Franklin R. 2000. Remyelination occurs as extensively but more slowly in old rats compared to young rats following fliotoxin-induced CNS demyelination. Glia 28:77-83.
69. Shilatifard A. 2006. Chromatin modifications by methylation and ubiquitination: Implications in the regulation of gene expression. Annu Rev Biochem 75:243-269. (Pubitemid 44118033)
70. Siebzehnrubl FA, Buslei R, Eyupoglu IY, Seufert S, Hahnen E, Blumcke I. 2007. Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells. Exp Brain Res 176:672-678. (Pubitemid 46175198)
71. Sim FJ, Zhao C, Penderis J, Franklin RJ. 2002. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci 22:2451-2459. (Pubitemid 37465793)
72. Sims RJ, III, Reinberg D. 2008. Is there a code embedded in proteins that is based on post-translational modifications? Nat Rev Mol Cell Biol 9:815-820.
73. Song MR, Ghosh A. 2004. FGF2-induced chromatin remodeling regulates CNTF-mediated gene expression and astrocyte differentiation. Nat Neurosci 7:229-235. (Pubitemid 38280446)
74. Sparmann A, Lohuizen van M. 2006. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6:846-856. (Pubitemid 44629896)
75. Tahiliani M, Mei P, Fang R, Leonor T, Rutenberg M, Shimizu F, Li J, Rao A, Shi Y. 2007. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 447:601-605. (Pubitemid 46868038)
76. Tang BL, Chua CE. 2008. SIRT2, tubulin deacetylation, and oligodendroglia differentiation. Cell Motil Cytoskeleton 65:179-182.
77. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I. 2008. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation Nature 455:1124-1128.
78. Thiagalingam S, Cheng KH, Lee HJ, Mineva N, Thiagalingam A, Ponte JF. 2003. Histone deacetylases: Unique players in shaping the epigenetic histone code. Ann NY Acad Sci 983:84-100. (Pubitemid 36399322)
79. Tranquill LR, Cao L, Ling NC, Kalbacher H, Martin RM, Whitaker JN. 2000. Enhanced T cell responsiveness to citrulline-containing myelin basic protein in multiple sclerosis patients. Mult Scler 6:220-225. (Pubitemid 30675985)
80. Vallstedt A, Klos JM, Ericson J. 2005. Multiple dorsoventral origins of oligodendrocyte generation in the spinal cord and hindbrain. Neuron 45:55-67. (Pubitemid 40075349)
81. Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, Reinberg D. 2004. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell 16:93-105. (Pubitemid 39330155)
82. Vaquero A, Sternglanz R, Reinberg D. 2007. NAD1-dependent deacetylation of H4 lysine 16 by class III HDACs. Oncogene 26:5505-5520. (Pubitemid 47255931)
83. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM. 2002. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419:624-629.
84. Vaziri H, Dessain SK, Ng EE, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA. 2001. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107:149-159. (Pubitemid 33035942)
85. Wang Y, Wysocka J, Sayegh J, Lee YH, Perlin JR, Leonelli L, Sonbuchner LS, McDonald CH, Cook RG, Dou Y, Roeder RG, Clarke S, Stallcup MR, Allis CD, Coonrod SA. 2004. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306:279-283. (Pubitemid 39336873)
86. Weake VM, Workman JL. 2008. Histone ubiquitination: Triggering gene activity. Mol Cell 29:653-663.
87. Wegner M. 2008. A matter of identity: Transcriptional control in oligodendrocytes. J Mol Neurosci 35:3-12.
88. Wei Q, Miskimins WK, Miskimins R. 2005. Stage-specific expression of myelin basic protein in oligodendrocytes involves Nkx2.2-mediated repression that is relieved by the Sp1 transcription factor. J Biol Chem 280:16284-16294. (Pubitemid 40616756)
89. Werner HB, Kuhlmann K, Shen S, Uecker M, Schardt A, Dimova K, Orfaniotou F, Dhaunchak A, Brinkmann BG, Mobius W, Guarente L, Casaccia-Bonnefil P, Jahn O, Nave KA. 2007. Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J Neurosci 27:7717-7730. (Pubitemid 47093807)
90. Wood DD, Ackerley CA, Brand B, Zhang L, Raijmakers R, Mastronardi FG, Moscarello MA. 2008. Myelin localization of peptidylarginine deiminases 2 and 4: Comparison of PAD2 and PAD4 activities. Lab Invest 88:354-364.
91. Wood DD, Moscarello MA. 1989. The isolation, characterization, and lipid-aggregating properties of a citrulline containing myelin basic protein. J Biol Chem 264:5121-5127.
92. Woodruff RH, Fruttiger M, Richardson WD, Franklin RJ. 2004. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS, their response following CNS demyelination. Mol Cell Neurosci 25:252-262. (Pubitemid 38344108)
93. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. 2004. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23:2369-2380. (Pubitemid 38954844)
94. Zhao Y, Ransom JF, Li A, Vedantham V, von DM, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D. 2007. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129:303-317.
95. Zhou SR, Moscarello MA, Whitaker JN. 1995. The effects of citrullination or variable amino-terminus acylation on the encephalitogenicity of human myelin basic protein in the PL/J mouse. J Neuroimmunol 62:147-152.
96. Zhou X, Richon VM, Rifkind RA, Marks PA. 2000. Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5. Proc Natl Acad Sci USA 97:1056-1061. (Pubitemid 30080811)